UNSPSC 51313400: Antihistamine or H1 blocker pyridines

Antihistamine or H1 blocker drugs made from compounds with a six membered aromatic ring containing NITROGEN.

UNSPSC 51313400 Antihistamine or H1 blocker pyridines, a Class code, does not align with the recent state and local opportunities posted under this classification. The three most recent opportunities involve naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), and generic multi-source pharmaceuticals and OTC products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations concern antihistamine or H1 blocker pyridine products specifically. The mismatch suggests either a tagging error in the source data or minimal recent procurement activity aligned with the code's stated pharmaceutical category.

The issuing bodies include a county government (Seminole County), a state health agency (Texas HHS), and a multistate cooperative purchasing vehicle (MMCAP). Geographic activity spans Florida, Texas, and the MMCAP member jurisdictions including Minnesota and Oregon. The recent opportunities—an IFB for naloxone and drug deactivation systems (due July 26, 2023), an RFI for direct prescription fulfillment (response deadline April 3, 2026), and an RFP for generic pharmaceuticals and OTC products through authorized wholesalers (due March 26, 2026)—represent broader pharmaceutical procurement rather than the antihistamine category this code nominally covers. Without evidence of recent state and local solicitations specifically targeting antihistamine or H1 blocker pyridine products, this code shows little relevant recent activity in the tracked opportunities.